- Filed
- Mar 30, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2022 · Mar 30, 2023 | 14.2M sh |
| Shares Diluted | FY 2022 · Dec 31, 2021 | 16.63M sh |
| Capex | FY 2022 · Dec 31, 2021 | $221.84K |
| Operating Cash Flow restated | FY 2022 · Dec 31, 2021 | $861.27K |
| Cash And Equivalents | FY 2022 · Dec 31, 2021 | $1.8M |
| Current Liabilities | FY 2022 · Dec 31, 2021 | $1.29M |
| Total Liabilities | FY 2022 · Dec 31, 2021 | $3.95M |
| Current Assets | FY 2022 · Dec 31, 2021 | $5.87M |
| Total Assets | FY 2022 · Dec 31, 2021 | $7.27M |
| Eps Diluted | FY 2022 · Dec 31, 2021 | $0.11 |
| Eps Basic | FY 2022 · Dec 31, 2021 | $0.13 |
| Sga Expense | FY 2022 · Dec 31, 2021 | $2.54M |
| Net Income | FY 2022 · Dec 31, 2021 | $1.75M |
| Operating Income | FY 2022 · Dec 31, 2021 | $934.35K |
| Cost Of Revenue | FY 2022 · Dec 31, 2021 | $7.87M |
| Stockholders Equity | FY 2022 · Dec 31, 2020 | $1.35M |